Published in Neurology on September 01, 1998
Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A (2000) 4.83
Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol (2007) 3.13
Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest (2006) 2.86
Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet (2011) 2.29
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
The role of parkin in familial and sporadic Parkinson's disease. Mov Disord (2010) 1.90
The neuropathology of genetic Parkinson's disease. Mov Disord (2012) 1.73
The genetics of Parkinson disease. J Geriatr Psychiatry Neurol (2010) 1.69
Parkin disease: a clinicopathologic entity? JAMA Neurol (2013) 1.68
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
The genetics and neuropathology of Parkinson's disease. Acta Neuropathol (2012) 1.56
How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep (2004) 1.54
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol (2002) 1.54
Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway. Autophagy (2007) 1.50
α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol (2012) 1.42
Parkin mediates the degradation-independent ubiquitination of Hsp70. J Neurochem (2008) 1.42
Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging (2008) 1.41
Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease? Front Neuroanat (2016) 1.39
The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet (2003) 1.30
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J Neurol Neurosurg Psychiatry (2007) 1.24
Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Mol Biol Cell (2003) 1.23
Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx (2005) 1.22
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. BMC Neurosci (2004) 1.12
Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet (2004) 1.11
Genetic neuropathology of Parkinson's disease. Int J Clin Exp Pathol (2008) 1.11
The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun (2013) 1.11
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
Genetics of parkin-linked disease. Hum Genet (2004) 1.04
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. Biochim Biophys Acta (2009) 1.02
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem (2011) 0.96
Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Mol Neurodegener (2010) 0.95
Mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis (2011) 0.93
Role of the ubiquitin proteasome system in Parkinson's disease. BMC Biochem (2007) 0.91
Progress in the pathogenesis and genetics of Parkinson's disease. Philos Trans R Soc Lond B Biol Sci (2008) 0.91
α-Synuclein and mitochondrial dysfunction in Parkinson's disease. Mol Neurobiol (2013) 0.91
Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update. Front Neuroanat (2014) 0.90
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet (2011) 0.90
Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Parkinsonism Relat Disord (2009) 0.87
Genetically engineered mouse models of Parkinson's disease. Brain Res Bull (2011) 0.86
Parkin disease and the Lewy body conundrum. Mov Disord (2013) 0.84
Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. Cell Mol Life Sci (2014) 0.82
123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. J Neurol (2011) 0.81
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism. BMC Neurol (2008) 0.80
Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett (2015) 0.78
Pathologic and therapeutic implications for the cell biology of parkin. Mol Cell Neurosci (2015) 0.78
The multiple mechanisms of amyloid deposition: the role of parkin. Prion (2009) 0.77
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. BMJ Case Rep (2009) 0.77
Nonmotor Symptoms in Patients with PARK2 Mutations. Parkinsons Dis (2011) 0.77
A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics. Parkinsonism Relat Disord (2015) 0.76
The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases. Front Psychiatry (2010) 0.76
Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations. J Neurol (2006) 0.75
Parkinson's disease. Ann Indian Acad Neurol (2011) 0.75
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology (1999) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA. Nucleic Acids Res (1981) 9.56
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet (2000) 7.83
Expression of a gene cluster kaiABC as a circadian feedback process in cyanobacteria. Science (1998) 7.38
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A (2001) 6.07
Peopling of the Americas, founded by four major lineages of mitochondrial DNA. Mol Biol Evol (1993) 4.50
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell (2001) 4.41
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (2001) 4.18
Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol (1996) 4.06
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98
Circadian orchestration of gene expression in cyanobacteria. Genes Dev (1995) 3.95
Resonating circadian clocks enhance fitness in cyanobacteria. Proc Natl Acad Sci U S A (1998) 3.84
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41
All for one and one for all: condensations and the initiation of skeletal development. Bioessays (2000) 3.40
Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol (1998) 3.39
Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol (1999) 3.38
A kaiC-interacting sensory histidine kinase, SasA, necessary to sustain robust circadian oscillation in cyanobacteria. Cell (2000) 3.31
Solid-phase synthesis of polynucleotides. II. Synthesis of polythymidylic acids by the block coupling phosphotriester method. Nucleic Acids Res (1980) 3.20
Nucleotide binding and autophosphorylation of the clock protein KaiC as a circadian timing process of cyanobacteria. Proc Natl Acad Sci U S A (2000) 3.17
Physical interactions among circadian clock proteins KaiA, KaiB and KaiC in cyanobacteria. EMBO J (1999) 2.97
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A (1996) 2.88
Purification of human erythropoietin. J Biol Chem (1977) 2.83
Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet (1995) 2.65
One subspecies of the red junglefowl (Gallus gallus gallus) suffices as the matriarchic ancestor of all domestic breeds. Proc Natl Acad Sci U S A (1994) 2.64
Circadian oscillations of cytosolic and chloroplastic free calcium in plants. Science (1995) 2.63
Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse (2001) 2.56
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock. Science (2000) 2.50
Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A (1998) 2.42
Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39
Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39
Import of proteins into mitochondria: a 70 kilodalton outer membrane protein with a large carboxy-terminal deletion is still transported to the outer membrane. EMBO J (1983) 2.33
Isolation of the nuclear yeast genes for citrate synthase and fifteen other mitochondrial proteins by a new screening method. EMBO J (1984) 2.33
Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol (1989) 2.28
Monophyletic origin and unique dispersal patterns of domestic fowls. Proc Natl Acad Sci U S A (1996) 2.27
Circadian clocks in prokaryotes. Mol Microbiol (1996) 2.25
Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation (1995) 2.24
Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res (2001) 2.22
Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem (1999) 2.21
Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett (1994) 2.17
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun (1996) 2.09
Pie1, a protein interacting with Mec1, controls cell growth and checkpoint responses in Saccharomyces cerevisiae. Mol Cell Biol (2001) 2.09
Isolation of cytopathic small round virus (Aichi virus) from Pakistani children and Japanese travelers from Southeast Asia. Microbiol Immunol (1995) 2.06
Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol (1991) 2.05
Of fingers, toes and penises. Nature (1997) 2.00
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ (2005) 1.98
Import of proteins into mitochondria: nucleotide sequence of the gene for a 70-kd protein of the yeast mitochondrial outer membrane. EMBO J (1983) 1.97
Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int J Dev Biol (1995) 1.95
Two-dimensional electron gas with universal subbands at the surface of SrTiO(3). Nature (2011) 1.94
Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation (1999) 1.89
hsk1+, a Schizosaccharomyces pombe gene related to Saccharomyces cerevisiae CDC7, is required for chromosomal replication. EMBO J (1995) 1.89
Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol (1999) 1.86
ATP-dependent proteases that also chaperone protein biogenesis. Trends Biochem Sci (1997) 1.85
Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. Science (1994) 1.82
Reciprocal group I inhibition on triceps surae motoneurons in man. J Neurophysiol (1971) 1.81
Targeted inversion of a polar silencer within the HoxD complex re-allocates domains of enhancer sharing. Nat Genet (2000) 1.78
Isolation of a possible fourth group of RNA phage. Jpn J Microbiol (1968) 1.78
Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr (1994) 1.76
Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem (2001) 1.76
Histopathological studies of superficial-type early colorectal carcinoma. Cancer (1996) 1.76
Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nurs (1997) 1.76
c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene (2006) 1.69
Two KaiA-binding domains of cyanobacterial circadian clock protein KaiC. FEBS Lett (2001) 1.67
Free radical formation induced by ultrasound and its biological implications. Free Radic Biol Med (1992) 1.67
Point mutations in mitochondrial tRNA genes: sequence analysis of chronic progressive external ophthalmoplegia (CPEO) J Neurol Sci (1994) 1.65
Sugar permeases of the bacterial phosphoenolpyruvate-dependent phosphotransferase system: sequence comparisons. FASEB J (1988) 1.64
Extra-long first-strand cDNA synthesis. Biotechniques (2002) 1.64
Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem (1999) 1.64
Total synthesis of a RNA molecule with sequence identical to that of Escherichia coli formylmethionine tRNA. Proc Natl Acad Sci U S A (1981) 1.63
Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol (2000) 1.63
Grouping of RNA phages based on the template specificity of their RNA replicases. Proc Natl Acad Sci U S A (1971) 1.62
Sequencing of the nuclear gene for the yeast cytochrome c1 precursor reveals an unusually complex amino-terminal presequence. EMBO J (1984) 1.61
Bacterial luciferase as a reporter of circadian gene expression in cyanobacteria. J Bacteriol (1995) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest (1988) 1.60
Bacterial Na(+)-ATP synthase has an undecameric rotor. EMBO Rep (2001) 1.59
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther (2015) 1.59
Nerve growth factor in mouse and rat serum: correlation between bioassay and radioimmunoassay determinations. Proc Natl Acad Sci U S A (1978) 1.59
The use of a nasogastric tube as an aid in blind nasotracheal intubation. Anesthesiology (1992) 1.59
Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J Cell Biol (1993) 1.58
The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat Embryol (Berl) (1992) 1.57
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
New pathologic observations in juvenile onset parkinsonism with dystonia. Neurology (1991) 1.57
Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet (1997) 1.56
cpmA, a gene involved in an output pathway of the cyanobacterial circadian system. J Bacteriol (1999) 1.56
Genome-wide profiling of promoter methylation in human. Oncogene (2006) 1.55
Rfc5, in cooperation with rad24, controls DNA damage checkpoints throughout the cell cycle in Saccharomyces cerevisiae. Mol Cell Biol (2000) 1.54
Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. J Hepatol (1997) 1.54